New Leaf Venture Partners, L.L.C. Rallybio Corp Transaction History
New Leaf Venture Partners, L.L.C.
- $114 Million
- Q1 2024
A detailed history of New Leaf Venture Partners, L.L.C. transactions in Rallybio Corp stock. As of the latest transaction made, New Leaf Venture Partners, L.L.C. holds 3,301,603 shares of RLYB stock, worth $4.49 Million. This represents 5.35% of its overall portfolio holdings.
Number of Shares
3,301,603
Previous 3,301,603
-0.0%
Holding current value
$4.49 Million
Previous $7.89 Million
22.6%
% of portfolio
5.35%
Previous 6.37%
Shares
2 transactions
Others Institutions Holding RLYB
# of Institutions
64Shares Held
30.7MCall Options Held
0Put Options Held
0-
Viking Global Investors LP4.19MShares$5.7 Million0.03% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA3.63MShares$4.94 Million2.37% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX3.03MShares$4.12 Million0.12% of portfolio
-
Pivotal Bio Venture Partners Investment Advisor LLC San Francisco, CA2.4MShares$3.27 Million3.26% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA2.06MShares$2.8 Million4.2% of portfolio
About Rallybio Corp
- Ticker RLYB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 32,132,000
- Market Cap $43.7M
- Description
- Rallybio Corporation, a clinical-stage biotechnology company, engages in discovering, developing, manufacturing, and delivering therapies that enhance the lives of patients suffering from severe and rare diseases. Its lead product candidate is RLYB212, a monoclonal anti-HPA-1a antibody that is in Phase I clinical trial for the prevention of feta...